SAN CARLOS, Calif., Oct. 30, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its third quarter ended September 30, 2019, after the market close on November 6, 2019. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.
|
Earnings Conference Call Information:
|
|
Event:
|
Natera's Third Quarter 2019 Financial Results Conference Call
|
|
Date:
|
Wednesday, November 6, 2019
|
|
Time:
|
1:30 p.m. PT (4:30 p.m. ET)
|
|
Live Dial-In:
|
(877) 823-0171, Domestic
|
| |
(617) 500-6932, International
|
|
Conference ID:
|
4354617
|
|
Webcast:
|
https://edge.media-server.com/mmc/p/vv47vu54
|
A webcast replay will be available at investor.natera.com.
About Natera
Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on reproductive health, oncology, and organ transplantation. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.
Contacts
Investor Relations
Mike Brophy, CFO, Natera, 650-249-9090
Media
Allison Rogan, pr@natera.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-announces-third-quarter-2019-earnings-conference-call-300947841.html
SOURCE Natera, Inc.